APO Research
Talk to an analyst

APO RESEARCH · REPORT

RFID for Pharmaceutical

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global RFID for Pharmaceutical Market Analysis and Forecast 2026-2032

5 March 2026199 pages

Choose your research edition.

Industry ResearchRFID for Pharmaceutical Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal RFID for Pharmaceutical Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal RFID for Pharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RFID for Pharmaceutical Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal RFID for Pharmaceutical Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global RFID for Pharmaceutical market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for RFID for Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for RFID for Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for RFID for Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for RFID for Pharmaceutical is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of RFID for Pharmaceutical include Terso Solutions, iGPS, Dipole, GAO Group, Turck, Avery Dennison, Aucxis, Murata Manufacturing and BIXOLON, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for RFID for Pharmaceutical, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of RFID for Pharmaceutical, also provides the revenue of main regions and countries. Of the upcoming market potential for RFID for Pharmaceutical, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the RFID for Pharmaceutical revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global RFID for Pharmaceutical market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for RFID for Pharmaceutical revenue, projected growth trends, production technology, application and end-user industry.

RFID for Pharmaceutical Segment by Company

Terso Solutions

iGPS

Dipole

GAO Group

Turck

Avery Dennison

Aucxis

Murata Manufacturing

BIXOLON

Bionix Technologies

Tageos

Zebra Technologies

Checkpoint Systems (CCL Industries)

SML

RFID for Pharmaceutical Segment by Type

Tag

Printer

Others

RFID for Pharmaceutical Segment by Application

Inventory Management

Logistics Tracking

Others

RFID for Pharmaceutical Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RFID for Pharmaceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RFID for Pharmaceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RFID for Pharmaceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of RFID for Pharmaceutical in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of RFID for Pharmaceutical company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, RFID for Pharmaceutical revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global RFID for Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Tag Major Player Table 3. Printer Major Player Table 4. Others Major Player Table 5. Global RFID for Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Inventory Management Major Player Table 7. Logistics Tracking Major Player Table 8. Others Major Player Table 9. RFID for Pharmaceutical Industry Trends Table 10. RFID for Pharmaceutical Industry Drivers Table 11. RFID for Pharmaceutical Industry Opportunities and Challenges Table 12. RFID for Pharmaceutical Industry Restraints Table 13. Global RFID for Pharmaceutical Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global RFID for Pharmaceutical Market Size by Region (2021-2026) & (US$ Million) Table 15. Global RFID for Pharmaceutical Market Share by Region (2021-2026) Table 16. Global RFID for Pharmaceutical Market Size by Region (2027-2032) & (US$ Million) Table 17. Global RFID for Pharmaceutical Market Share by Region (2027-2032) Table 18. Global RFID for Pharmaceutical Revenue by Players (US$ Million) & (2021-2026) Table 19. Global RFID for Pharmaceutical Revenue Market Share by Players (2021-2026) Table 20. Global RFID for Pharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global RFID for Pharmaceutical Key Players Headquarters & Area Served Table 22. Global RFID for Pharmaceutical Players, Product Type & Application Table 23. Global RFID for Pharmaceutical Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global RFID for Pharmaceutical by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global RFID for Pharmaceutical Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 28. Global RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 29. Global RFID for Pharmaceutical Revenue Market Share by Type (2021-2026) Table 30. Global RFID for Pharmaceutical Revenue Market Share by Type (2027-2032) Table 31. Global RFID for Pharmaceutical Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 33. Global RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 34. Global RFID for Pharmaceutical Revenue Market Share by Application (2021-2026) Table 35. Global RFID for Pharmaceutical Revenue Market Share by Application (2027-2032) Table 36. Terso Solutions Company Information Table 37. Terso Solutions Business Overview Table 38. Terso Solutions RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Terso Solutions RFID for Pharmaceutical Product Portfolio Table 40. Terso Solutions Recent Development Table 41. iGPS Company Information Table 42. iGPS Business Overview Table 43. iGPS RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. iGPS RFID for Pharmaceutical Product Portfolio Table 45. iGPS Recent Development Table 46. Dipole Company Information Table 47. Dipole Business Overview Table 48. Dipole RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Dipole RFID for Pharmaceutical Product Portfolio Table 50. Dipole Recent Development Table 51. GAO Group Company Information Table 52. GAO Group Business Overview Table 53. GAO Group RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. GAO Group RFID for Pharmaceutical Product Portfolio Table 55. GAO Group Recent Development Table 56. Turck Company Information Table 57. Turck Business Overview Table 58. Turck RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Turck RFID for Pharmaceutical Product Portfolio Table 60. Turck Recent Development Table 61. Avery Dennison Company Information Table 62. Avery Dennison Business Overview Table 63. Avery Dennison RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Avery Dennison RFID for Pharmaceutical Product Portfolio Table 65. Avery Dennison Recent Development Table 66. Aucxis Company Information Table 67. Aucxis Business Overview Table 68. Aucxis RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Aucxis RFID for Pharmaceutical Product Portfolio Table 70. Aucxis Recent Development Table 71. Murata Manufacturing Company Information Table 72. Murata Manufacturing Business Overview Table 73. Murata Manufacturing RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Murata Manufacturing RFID for Pharmaceutical Product Portfolio Table 75. Murata Manufacturing Recent Development Table 76. BIXOLON Company Information Table 77. BIXOLON Business Overview Table 78. BIXOLON RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. BIXOLON RFID for Pharmaceutical Product Portfolio Table 80. BIXOLON Recent Development Table 81. Bionix Technologies Company Information Table 82. Bionix Technologies Business Overview Table 83. Bionix Technologies RFID for Pharmaceutical Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bionix Technologies RFID for Pharmaceutical Product Portfolio Table 85. Bionix Technologies Recent Development Table 86. Tageos Company Information Table 87. Tageos Business Overview Table 88. Tageos RFID for Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Tageos RFID for Pharmaceutical Product Portfolio Table 90. Tageos Recent Development Table 91. Zebra Technologies Company Information Table 92. Zebra Technologies Business Overview Table 93. Zebra Technologies RFID for Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Zebra Technologies RFID for Pharmaceutical Product Portfolio Table 95. Zebra Technologies Recent Development Table 96. Checkpoint Systems (CCL Industries) Company Information Table 97. Checkpoint Systems (CCL Industries) Business Overview Table 98. Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Product Portfolio Table 100. Checkpoint Systems (CCL Industries) Recent Development Table 101. SML Company Information Table 102. SML Business Overview Table 103. SML RFID for Pharmaceutical Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. SML RFID for Pharmaceutical Product Portfolio Table 105. SML Recent Development Table 106. North America RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 107. North America RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 108. North America RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 109. North America RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 110. North America RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America RFID for Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 112. North America RFID for Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 113. Europe RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 114. Europe RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 115. Europe RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 116. Europe RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 117. Europe RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. Europe RFID for Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 119. Europe RFID for Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 120. China RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 121. China RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 122. China RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 123. China RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 125. Asia RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 126. Asia RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 127. Asia RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 128. Asia RFID for Pharmaceutical Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 129. Asia RFID for Pharmaceutical Revenue by Region (US$ Million) & (2021-2026) Table 130. Asia RFID for Pharmaceutical Revenue by Region (US$ Million) & (2027-2032) Table 131. SAMEA RFID for Pharmaceutical Revenue by Type (2021-2026) & (US$ Million) Table 132. SAMEA RFID for Pharmaceutical Revenue by Type (2027-2032) & (US$ Million) Table 133. SAMEA RFID for Pharmaceutical Revenue by Application (2021-2026) & (US$ Million) Table 134. SAMEA RFID for Pharmaceutical Revenue by Application (2027-2032) & (US$ Million) Table 135. SAMEA RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 136. SAMEA RFID for Pharmaceutical Revenue by Country (2021-2026) & (US$ Million) Table 137. SAMEA RFID for Pharmaceutical Revenue by Country (US$ Million) & (2027-2032) Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. RFID for Pharmaceutical Image Figure 2. Global RFID for Pharmaceutical Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RFID for Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 4. Tag Image Figure 5. Printer Image Figure 6. Others Image Figure 7. Global RFID for Pharmaceutical Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global RFID for Pharmaceutical Market Size Share 2021 VS 2025 VS 2032 Figure 9. Inventory Management Image Figure 10. Logistics Tracking Image Figure 11. Others Image Figure 12. Global RFID for Pharmaceutical Market Size (US$ Million) & (2021-2032) Figure 13. Global RFID for Pharmaceutical Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global RFID for Pharmaceutical Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global RFID for Pharmaceutical Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global RFID for Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global RFID for Pharmaceutical Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global RFID for Pharmaceutical Revenue Market Share by Type (2021-2032) Figure 20. Global RFID for Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global RFID for Pharmaceutical Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global RFID for Pharmaceutical Revenue Market Share by Application (2021-2032) Figure 23. North America RFID for Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America RFID for Pharmaceutical Revenue Share by Type (2021-2032) Figure 25. North America RFID for Pharmaceutical Revenue Share by Application (2021-2032) Figure 26. North America RFID for Pharmaceutical Revenue Share by Country (2021-2032) Figure 27. United States RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe RFID for Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe RFID for Pharmaceutical Revenue Share by Type (2021-2032) Figure 32. Europe RFID for Pharmaceutical Revenue Share by Application (2021-2032) Figure 33. Europe RFID for Pharmaceutical Revenue Share by Country (2021-2032) Figure 34. Germany RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China RFID for Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China RFID for Pharmaceutical Revenue Share by Type (2021-2032) Figure 44. China RFID for Pharmaceutical Revenue Share by Application (2021-2032) Figure 45. Asia RFID for Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia RFID for Pharmaceutical Revenue Share by Type (2021-2032) Figure 47. Asia RFID for Pharmaceutical Revenue Share by Application (2021-2032) Figure 48. Asia RFID for Pharmaceutical Revenue Share by Region (2021-2032) Figure 49. Japan RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA RFID for Pharmaceutical Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA RFID for Pharmaceutical Revenue Share by Type (2021-2032) Figure 57. SAMEA RFID for Pharmaceutical Revenue Share by Application (2021-2032) Figure 58. SAMEA RFID for Pharmaceutical Revenue Share by Country (2021-2032) Figure 59. Brazil RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt RFID for Pharmaceutical Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Tag
  • Printer
  • Others
Applications
  • Inventory Management
  • Logistics Tracking
  • Others
Companies covered
  • Terso Solutions
  • iGPS
  • Dipole
  • GAO Group
  • Turck
  • Avery Dennison
  • Aucxis
  • Murata Manufacturing
  • BIXOLON
  • Bionix Technologies
  • Tageos
  • Zebra Technologies
  • Checkpoint Systems (CCL Industries)
  • SML

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 RFID for Pharmaceutical Market by Type
  3. 1.2.1 Global RFID for Pharmaceutical Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Tag
  5. 1.2.3 Printer
  6. 1.2.4 Others
  7. 1.3 RFID for Pharmaceutical Market by Application
  8. 1.3.1 Global RFID for Pharmaceutical Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Inventory Management
  10. 1.3.3 Logistics Tracking
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 RFID for Pharmaceutical Market Dynamics
  1. 2.1 RFID for Pharmaceutical Industry Trends
  2. 2.2 RFID for Pharmaceutical Industry Drivers
  3. 2.3 RFID for Pharmaceutical Industry Opportunities and Challenges
  4. 2.4 RFID for Pharmaceutical Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global RFID for Pharmaceutical Market Perspective (2021-2032)
  2. 3.2 Global RFID for Pharmaceutical Growth Trends by Region
  3. 3.2.1 Global RFID for Pharmaceutical Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global RFID for Pharmaceutical Market Size by Region (2021-2026)
  5. 3.2.3 Global RFID for Pharmaceutical Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global RFID for Pharmaceutical Revenue by Players
  2. 4.1.1 Global RFID for Pharmaceutical Revenue by Players (2021-2026)
  3. 4.1.2 Global RFID for Pharmaceutical Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global RFID for Pharmaceutical Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global RFID for Pharmaceutical Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global RFID for Pharmaceutical Key Players Headquarters & Area Served
  7. 4.4 Global RFID for Pharmaceutical Players, Product Type & Application
  8. 4.5 Global RFID for Pharmaceutical Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global RFID for Pharmaceutical Market CR5 and HHI
  11. 4.6.3 2025 RFID for Pharmaceutical Tier 1, Tier 2, and Tier 3
5 RFID for Pharmaceutical Market Size by Type
  1. 5.1 Global RFID for Pharmaceutical Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 5.3 Global RFID for Pharmaceutical Revenue Market Share by Type (2021-2032)
6 RFID for Pharmaceutical Market Size by Application
  1. 6.1 Global RFID for Pharmaceutical Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global RFID for Pharmaceutical Revenue by Application (2021-2032)
  3. 6.3 Global RFID for Pharmaceutical Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Terso Solutions
  2. 7.1.1 Terso Solutions Company Information
  3. 7.1.2 Terso Solutions Business Overview
  4. 7.1.3 Terso Solutions RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Terso Solutions RFID for Pharmaceutical Product Portfolio
  6. 7.1.5 Terso Solutions Recent Developments
  7. 7.2 iGPS
  8. 7.2.1 iGPS Company Information
  9. 7.2.2 iGPS Business Overview
  10. 7.2.3 iGPS RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  11. 7.2.4 iGPS RFID for Pharmaceutical Product Portfolio
  12. 7.2.5 iGPS Recent Developments
  13. 7.3 Dipole
  14. 7.3.1 Dipole Company Information
  15. 7.3.2 Dipole Business Overview
  16. 7.3.3 Dipole RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Dipole RFID for Pharmaceutical Product Portfolio
  18. 7.3.5 Dipole Recent Developments
  19. 7.4 GAO Group
  20. 7.4.1 GAO Group Company Information
  21. 7.4.2 GAO Group Business Overview
  22. 7.4.3 GAO Group RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GAO Group RFID for Pharmaceutical Product Portfolio
  24. 7.4.5 GAO Group Recent Developments
  25. 7.5 Turck
  26. 7.5.1 Turck Company Information
  27. 7.5.2 Turck Business Overview
  28. 7.5.3 Turck RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Turck RFID for Pharmaceutical Product Portfolio
  30. 7.5.5 Turck Recent Developments
  31. 7.6 Avery Dennison
  32. 7.6.1 Avery Dennison Company Information
  33. 7.6.2 Avery Dennison Business Overview
  34. 7.6.3 Avery Dennison RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Avery Dennison RFID for Pharmaceutical Product Portfolio
  36. 7.6.5 Avery Dennison Recent Developments
  37. 7.7 Aucxis
  38. 7.7.1 Aucxis Company Information
  39. 7.7.2 Aucxis Business Overview
  40. 7.7.3 Aucxis RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Aucxis RFID for Pharmaceutical Product Portfolio
  42. 7.7.5 Aucxis Recent Developments
  43. 7.8 Murata Manufacturing
  44. 7.8.1 Murata Manufacturing Company Information
  45. 7.8.2 Murata Manufacturing Business Overview
  46. 7.8.3 Murata Manufacturing RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Murata Manufacturing RFID for Pharmaceutical Product Portfolio
  48. 7.8.5 Murata Manufacturing Recent Developments
  49. 7.9 BIXOLON
  50. 7.9.1 BIXOLON Company Information
  51. 7.9.2 BIXOLON Business Overview
  52. 7.9.3 BIXOLON RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BIXOLON RFID for Pharmaceutical Product Portfolio
  54. 7.9.5 BIXOLON Recent Developments
  55. 7.10 Bionix Technologies
  56. 7.10.1 Bionix Technologies Company Information
  57. 7.10.2 Bionix Technologies Business Overview
  58. 7.10.3 Bionix Technologies RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bionix Technologies RFID for Pharmaceutical Product Portfolio
  60. 7.10.5 Bionix Technologies Recent Developments
  61. 7.11 Tageos
  62. 7.11.1 Tageos Company Information
  63. 7.11.2 Tageos Business Overview
  64. 7.11.3 Tageos RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Tageos RFID for Pharmaceutical Product Portfolio
  66. 7.11.5 Tageos Recent Developments
  67. 7.12 Zebra Technologies
  68. 7.12.1 Zebra Technologies Company Information
  69. 7.12.2 Zebra Technologies Business Overview
  70. 7.12.3 Zebra Technologies RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Zebra Technologies RFID for Pharmaceutical Product Portfolio
  72. 7.12.5 Zebra Technologies Recent Developments
  73. 7.13 Checkpoint Systems (CCL Industries)
  74. 7.13.1 Checkpoint Systems (CCL Industries) Company Information
  75. 7.13.2 Checkpoint Systems (CCL Industries) Business Overview
  76. 7.13.3 Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Checkpoint Systems (CCL Industries) RFID for Pharmaceutical Product Portfolio
  78. 7.13.5 Checkpoint Systems (CCL Industries) Recent Developments
  79. 7.14 SML
  80. 7.14.1 SML Company Information
  81. 7.14.2 SML Business Overview
  82. 7.14.3 SML RFID for Pharmaceutical Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SML RFID for Pharmaceutical Product Portfolio
  84. 7.14.5 SML Recent Developments
8 North America
  1. 8.1 North America RFID for Pharmaceutical Revenue (2021-2032)
  2. 8.2 North America RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 8.2.1 North America RFID for Pharmaceutical Revenue by Type (2021-2026)
  4. 8.2.2 North America RFID for Pharmaceutical Revenue by Type (2027-2032)
  5. 8.3 North America RFID for Pharmaceutical Revenue Share by Type (2021-2032)
  6. 8.4 North America RFID for Pharmaceutical Revenue by Application (2021-2032)
  7. 8.4.1 North America RFID for Pharmaceutical Revenue by Application (2021-2026)
  8. 8.4.2 North America RFID for Pharmaceutical Revenue by Application (2027-2032)
  9. 8.5 North America RFID for Pharmaceutical Revenue Share by Application (2021-2032)
  10. 8.6 North America RFID for Pharmaceutical Revenue by Country
  11. 8.6.1 North America RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America RFID for Pharmaceutical Revenue by Country (2021-2026)
  13. 8.6.3 North America RFID for Pharmaceutical Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe RFID for Pharmaceutical Revenue (2021-2032)
  2. 9.2 Europe RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 9.2.1 Europe RFID for Pharmaceutical Revenue by Type (2021-2026)
  4. 9.2.2 Europe RFID for Pharmaceutical Revenue by Type (2027-2032)
  5. 9.3 Europe RFID for Pharmaceutical Revenue Share by Type (2021-2032)
  6. 9.4 Europe RFID for Pharmaceutical Revenue by Application (2021-2032)
  7. 9.4.1 Europe RFID for Pharmaceutical Revenue by Application (2021-2026)
  8. 9.4.2 Europe RFID for Pharmaceutical Revenue by Application (2027-2032)
  9. 9.5 Europe RFID for Pharmaceutical Revenue Share by Application (2021-2032)
  10. 9.6 Europe RFID for Pharmaceutical Revenue by Country
  11. 9.6.1 Europe RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe RFID for Pharmaceutical Revenue by Country (2021-2026)
  13. 9.6.3 Europe RFID for Pharmaceutical Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China RFID for Pharmaceutical Revenue (2021-2032)
  2. 10.2 China RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 10.2.1 China RFID for Pharmaceutical Revenue by Type (2021-2026)
  4. 10.2.2 China RFID for Pharmaceutical Revenue by Type (2027-2032)
  5. 10.3 China RFID for Pharmaceutical Revenue Share by Type (2021-2032)
  6. 10.4 China RFID for Pharmaceutical Revenue by Application (2021-2032)
  7. 10.4.1 China RFID for Pharmaceutical Revenue by Application (2021-2026)
  8. 10.4.2 China RFID for Pharmaceutical Revenue by Application (2027-2032)
  9. 10.5 China RFID for Pharmaceutical Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia RFID for Pharmaceutical Revenue (2021-2032)
  2. 11.2 Asia RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 11.2.1 Asia RFID for Pharmaceutical Revenue by Type (2021-2026)
  4. 11.2.2 Asia RFID for Pharmaceutical Revenue by Type (2027-2032)
  5. 11.3 Asia RFID for Pharmaceutical Revenue Share by Type (2021-2032)
  6. 11.4 Asia RFID for Pharmaceutical Revenue by Application (2021-2032)
  7. 11.4.1 Asia RFID for Pharmaceutical Revenue by Application (2021-2026)
  8. 11.4.2 Asia RFID for Pharmaceutical Revenue by Application (2027-2032)
  9. 11.5 Asia RFID for Pharmaceutical Revenue Share by Application (2021-2032)
  10. 11.6 Asia RFID for Pharmaceutical Revenue by Country
  11. 11.6.1 Asia RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia RFID for Pharmaceutical Revenue by Country (2021-2026)
  13. 11.6.3 Asia RFID for Pharmaceutical Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA RFID for Pharmaceutical Revenue (2021-2032)
  2. 12.2 SAMEA RFID for Pharmaceutical Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA RFID for Pharmaceutical Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA RFID for Pharmaceutical Revenue by Type (2027-2032)
  5. 12.3 SAMEA RFID for Pharmaceutical Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA RFID for Pharmaceutical Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA RFID for Pharmaceutical Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA RFID for Pharmaceutical Revenue by Application (2027-2032)
  9. 12.5 SAMEA RFID for Pharmaceutical Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA RFID for Pharmaceutical Revenue by Country
  11. 12.6.1 SAMEA RFID for Pharmaceutical Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA RFID for Pharmaceutical Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA RFID for Pharmaceutical Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst